Abstract
Wilms tumour was found in a Japanese boy aged 5 years 9 months with isolated growth hormone (GH) deficiency and some congenital anomalies. He had received pituitary GH replacement therapy from the age of 2 years 1 month to 4 years 7 months and after a 1 year interval he received biosynthetic GH for 2 months until the tumour became clinically apparent. This was the sixth known patient with GH deficiency to develop a malignant neoplasm during or after GH replacement therapy and the first with a solid tumour in Japan since 1975, when treatment with pituitary GH for patients with GH deficiency was introduced.
Article PDF
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
Abbreviations
- GH:
-
growth hormone
References
Arslanian SA, Becker DJ, Lee PA, Drash AL, Foley TP Jr (1985) Growth hormone therapy and tumor recurrence. Findings in children with brain neoplasms and hypopituitarism. Am J Dis Child 139:347–350
Bentley HP, Hughes ER, Peterson RDA (1975) Effect of hypophysectomy on a virus-induced T-cell leukemia. Nature 252:747–748
Blatt J, Wenger S, Stitely S, Lee PA (1987) Lack of mitogenic effects of growth hormone on human leukemic lymphoblasts. Eur J Pediatr 146:257–260
Boyd AE III, Jordan RM, Kohler PO (1986) Disorders of the hypothalamus and anterior pituitary. In: Kohler PO (ed) Clinical endocrinology. J Wiley, New York, pp 11–51
Brown P, Gajdusek DC, Gibbs CJ Jr, Asher DM (1985) Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy. N Engl J Med 313:728–731
Clayton PE, Shalet SM, Gattamaneni HR, Price DA (1987) Does growth hormone cause relapse of brain tumors? Lancet I:711–713
Daughaday WH (1985) The anterior pituitary. In: Wilson JD, Foster DW (eds) Textbook of endocrinology, Saunders, Philadelphia, pp 568–613
Delemarre-Van de Waal HA, Odink RJH, De Grauw TJ, De Waal FC (1988) Leukaemia in patients treated with growth hormone. Lancet I:1159
Fisher DA, Job JC, Preece M, Underwood, LE (1988) Leukaemia in patients treated with growth hormone. Lancet I:1159–1160
Greenwood MF, Holland P (1984) Clinical and biochemical manifestations of Wilms' tumor. In: Pochedly C, Baum ES (eds) Wilms' tumor. Clinical and biochemical manifestations. Elsevier, New York, pp 9–30
Hanawa Y (1975) Epidemiology of pediatric malignancies (in Japanese). Shonika Shinryo 38:1417–1424
Hirayama T (1980) Descriptive and analytical epidemiology of childhood malignancy in Japan. In: Kobayashi N (ed) Recent advances in management of children with cancer. The Children's Cancer Association in Japan, Tokyo, pp 27–43
Mercola KE, Cline MJ, Golde DW (1981) Growth hormone stimulation of normal and leukemic human T-lymphocyte proliferation in vitro. Blood 58:337–340
O'Neil JE (1987) Anaplastic astrocytoma associated with human growth hormone administration. J Neurol Neurosurg Psychiatry 50:1078
Rogers PC, Komp D, Rogol A, Sabio H (1977) Possible effects of growth hormone on development of acute lymphoblastic leukemia. Lancet II:434–435
Romshe CA, Zipf WB, Miser A, Miser J, Sotos JF, Newton WA (1984) Evaluation of growth hormone release and human growth hormone treatment in children with cranial irradiation-associated short stature. J Pediatr 104:177–181
Shalet SM (1986) Irradiation-induced growth failure. Clin Endocrinol Metab 15:591–606
Stahnke N, Zeisel HJ (1989) Growth hormone therapy and leukemia. Eur J Pediatr 148:591–596
Watanabe S, Tsunematsu Y, Fujimoto J, Komiyama A (1988) Leukemia in patients treated with growth hormone. Lancet I:1159
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Momoi, T., Yamanaka, C., Yorifuji, T. et al. Wilms tumour in a patient with growth hormone replacement therapy. Eur J Pediatr 149, 159–161 (1989). https://doi.org/10.1007/BF01958269
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01958269